Decoding FDA Guidance: Digital Health Technologies & GCP Oversight

Join this essential session as a panel of experts unpack the latest FDA guidance on digital health technologies (DHTs) and technology use in clinical trials. Gain clarity on what Good Clinical Practice (GCP) and other regulations truly require in terms of oversight and technology implementation. With ambiguity still surrounding these topics, this session will demystify key aspects, address common misconceptions, and provide actionable insights for research sites and sponsors.